Daniel D. Shoemaker, Chief Technology Officer at FATE THERAPEUTICS INC (FATE), sold 8,653 shares at $9.83 ($85K) on 2014-03-31, disclosed to the SEC on 2014-04-02.
Scheduled sale ($85k) by Chief Technology Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.83 | 8,253 | $81K | 95.0% |
| 2 | $10.57 | 400 | $4K | 5.0% |
| Total | $9.86 avg | 8,653 | $85K | 100% |
| Filing → |
| FATE | SELL | 2020-11-16 | $2.6M | — | Filing → |
| FATE | SELL | 2020-09-16 | $1.8M | — | Filing → |
| FATE | SELL | 2020-01-10 | $118K | — | Filing → |